Hydroxyzine Pamoate
- Product NDC
- 70934-444
- 11-digit product format
- 709340444
- Labeler code
- 70934
- Product ID
- 70934-444_a798f583-d691-728c-e053-2995a90af43a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyzine Pamoate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA040156
- Marketing category
- ANDA
- Marketing start
- 2019-09-19
- Marketing end
- 0000-00-00
- Substance
- HYDROXYZINE PAMOATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC],Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| M20215MUFR | HYDROXYZINE PAMOATE | 10246-75-0 | HYDROXYZINE PAMOATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-444-30 | 70934044430 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-444-30) | 30 capsule | 2019-09-19 | 0000-00-00 | No | No | Current |